Sinovac Biotech Ltd (SVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 10,954 | 22,952 | 16,764 | 18,491 | 9,207 |
| Cost of Goods | 4,626 | 7,288 | 5,549 | 3,283 | 2,308 |
| Gross Profit | 6,328 | 15,909 | 11,215 | 15,208 | 6,899 |
| Operating Expenses | 8,714 | 13,219 | 13,067 | 11,229 | 9,218 |
| Operating Income | -1,760 | 2,733 | -1,303 | 4,262 | -2,011 |
| Interest Expense | 383 | 430 | 493 | 421 | 588 |
| Other Income | 502 | -57 | 266 | 294 | 502 |
| Pre-tax Income | -1,641 | 2,246 | -1,530 | 4,135 | -2,097 |
| Income Tax | -52 | 1,735 | 267 | 440 | 551 |
| Net Income Continuous | -1,589 | 613 | -1,797 | 3,695 | -2,648 |
| Net Income Discontinuous | 2,338 | -109 | -183 | -244 | -192 |
| Minority Interests | -560 | 249 | -382 | 1,181 | -589 |
| Net Income | $1,309 | $504 | $-1,598 | $2,270 | $-2,251 |
| EPS Basic Total Ops | 0.02 | 0.01 | -0.03 | 0.04 | -0.04 |
| EPS Basic Continuous Ops | -0.03 | 0.01 | -0.03 | 0.07 | -0.05 |
| EPS Basic Discontinuous Ops | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted Total Ops | 0.02 | 0.01 | -0.03 | 0.04 | -0.04 |
| EPS Diluted Continuous Ops | -0.03 | 0.01 | -0.03 | 0.07 | -0.05 |
| EPS Diluted Discontinuous Ops | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA(a) | $-319 | $4,029 | $340 | $5,952 | $-391 |